NEW YORK, NY / ACCESS Newswire / December 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vistagen Therapeutics, Inc. ("Vistagen Therapeutics, Inc.") (NASDAQ:VTGN) concerning possible violations of federal securities laws. On December 17, 2025, before the market opened, Vistagen announced topline results from its PALISADE-3 Public Speaking Challenge […]

NEW YORK, NY / ACCESS Newswire / December 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Oxford Industries, Inc. ("Oxford Industries, Inc.") (NYSE:OXM) concerning possible violations of federal securities laws. On December 10, 2025, after the market closed, Oxford published third quarter results for fiscal 2025 showing decreased

NEW YORK, NY / ACCESS Newswire / December 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Oracle Corporation ("Oracle Corporation") (NYSE:ORCL) concerning possible violations of federal securities laws. What Happened? • On the evening of December 10, 2025, Oracle issued its second quarter earnings report for fiscal year

NEW YORK, NY / ACCESS Newswire / December 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of PagerDuty, Inc. ("PagerDuty, Inc.") (NYSE:PD) concerning possible violations of federal securities laws. On the evening of November 25, 2025, PagerDuty published results for the third quarter of fiscal 2026, disclosing a reduction

NEW YORK, NY / ACCESS Newswire / December 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Nutanix, Inc. ("Nutanix, Inc.") (NASDAQ:NTNX) concerning possible violations of federal securities laws. On November 25, 2025, after the market closed, Nutanix published first quarter fiscal 2026 revenue results that landed at the

NEW YORK, NY / ACCESS Newswire / December 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Lennox International Inc. ("Lennox International Inc.") (NYSE:LII) concerning possible violations of federal securities laws. On October 22, 2025, Lennox published mixed third quarter 2025 financial results. Particularly, the Company disclosed that it

NEW YORK, NY / ACCESS Newswire / December 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alector, Inc. ("Alector, Inc.") (NASDAQ:ALEC) concerning possible violations of federal securities laws. On October 22, 2025, Alector announced results from its Phase 2 INFRONT-3 clinical trial evaluating latozinemab (AL001) in patients with

NEW YORK, NY / ACCESS Newswire / December 26, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Stride, Inc. (NYSE:LRN) securities. If you suffered a loss on your Stride investment and would like to explore a potential recovery

NEW YORK, NY / ACCESS Newswire / December 26, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Synopsys, Inc. (NASDAQ:SNPS) securities. If you suffered a loss on your Synopsys, Inc. investment and would like to explore a potential

NEW YORK, NY / ACCESS Newswire / December 26, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Telix Pharmaceuticals Ltd. (NASDAQ:TLX) securities. If you suffered a loss on your Telix Pharmaceuticals Ltd. investment and would like to explore